Revealing the Treatment Landscape and Patient Pathways in a new Market

1 Pages

For a UK product launch in a market with no targeted treatments, IQVIA used its Longitudinal Patient Data (LPD) covering 8M+ records from 2,400 GPs. Pathway analysis showed patients waited an average of 273 days for primary care after diagnosis, with only 11% treated in primary care at all. Over five years, incidence dropped 20%, while treated patients rose just 8%. Despite uptake, 90% of patients remained untreated, with three products dominating 1st- and 2nd-line therapy. These findings guided launch planning, patient sizing, and market modeling.

Join for free to read

Case Study Preferred patient pathways

White Paper Industry pathways to net zero - Decarbonisation in manufacturing

White Paper Adapting to the Changing Landscape in Dialysis

Case Study Understand the regulatory environment, treatment pathways and…

More from IQVIA

Case Study Understand the regulatory environment, treatment pathways and…

Vendor Sheet Patient Insights: The Power of Prescription Data

Case Study Strategically Preparing for New Product Launch by Assessing the…

White Paper Digital Twins in Healthcare: Unlocking the Future of…

Case Study

Revealing the Treatment Landscape and Patient Pathways in a new Market

Revealing the Treatment Landscape and Patient Pathways in a new Market

You Might Also Like

More from IQVIA